In vitro and in vivo anti- Clostridioides difficile effect of a probiotic Bacillus amyloliquefaciens strain
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Islam Md Imtiazul | - |
dc.contributor.author | Seo Hoonhee | - |
dc.contributor.author | Redwan Asma | - |
dc.contributor.author | Kim Sukyung | - |
dc.contributor.author | Lee Saebim | - |
dc.contributor.author | Siddiquee Mashuk | - |
dc.contributor.author | 송호연 | - |
dc.date.accessioned | 2022-02-03T00:40:36Z | - |
dc.date.available | 2022-02-03T00:40:36Z | - |
dc.date.issued | 2022-01-28 | - |
dc.identifier.issn | 1017-7825 | - |
dc.identifier.issn | 1738-8872 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/20275 | - |
dc.description.abstract | Clostridioides difficile infection (CDI) is a significant cause of hospital-acquired and antibioticmediated intestinal diseases and is a growing global public health concern. Overuse of antibiotics and their effect on normal intestinal flora has increased the incidence and severity of infections. Thus, the development of new, effective, and safe treatment options is a high priority. Here, we report a new probiotic strain, Bacillus amyloliquefaciens (BA PMC-80), and its in vitro/in vivo anti-C. difficile effect as a prospective novel candidate for replacing conventional antibiotics. BA PMC-80 showed a significant anti-C. difficile effect in coculture assay, and its cell-free supernatant (CFS) also exhibited a considerable anti-C. difficile effect with an 89.06 μg/ml 50% minimal inhibitory concentration (MIC) in broth microdilution assay. The CFS was stable and equally functional under different pHs, heat, and proteinase treatments. It also exhibited a high sensitivity against current antibiotics and no toxicity in subchronic toxicity testing in hamsters. Finally, BA PMC-80 showed a moderate effect in a hamster CDI model with reduced infection severity and delayed death. However, further studies are required to optimize the treatment condition of the hamster CDI model for better efficacy and identify the antimicrobial compound produced by BA PMC-80. | - |
dc.format.extent | 10 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 한국미생물·생명공학회 | - |
dc.title | In vitro and in vivo anti- Clostridioides difficile effect of a probiotic Bacillus amyloliquefaciens strain | - |
dc.title.alternative | In Vitro and In Vivo Anti-Clostridioides difficile Effect of a Probiotic Bacillus amyloliquefaciens Strain | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.4014/jmb.2107.07057 | - |
dc.identifier.scopusid | 2-s2.0-85124030178 | - |
dc.identifier.wosid | 000767288300006 | - |
dc.identifier.bibliographicCitation | Journal of Microbiology and Biotechnology, v.32, no.1, pp 46 - 55 | - |
dc.citation.title | Journal of Microbiology and Biotechnology | - |
dc.citation.volume | 32 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 46 | - |
dc.citation.endPage | 55 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002807767 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
dc.relation.journalResearchArea | Microbiology | - |
dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
dc.relation.journalWebOfScienceCategory | Microbiology | - |
dc.subject.keywordPlus | ANTIBIOTIC-ASSOCIATED DIARRHEA | - |
dc.subject.keywordPlus | HAMSTER MODEL | - |
dc.subject.keywordPlus | TOXOID VACCINE | - |
dc.subject.keywordPlus | PREVENTION | - |
dc.subject.keywordPlus | INFECTION | - |
dc.subject.keywordPlus | EPIDEMIOLOGY | - |
dc.subject.keywordPlus | CHILDREN | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordAuthor | Clostridioides difficile | - |
dc.subject.keywordAuthor | Bacillus amyloliquefaciens | - |
dc.subject.keywordAuthor | BA PMC-80 | - |
dc.subject.keywordAuthor | probiotic | - |
dc.subject.keywordAuthor | antibiotic | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.